{"id":54913,"date":"2021-08-30T20:16:28","date_gmt":"2021-08-31T00:16:28","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=54913"},"modified":"2023-06-06T18:14:14","modified_gmt":"2023-06-06T22:14:14","slug":"parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/","title":{"rendered":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics"},"content":{"rendered":"<figure id=\"attachment_3504\" class=\"thumbnail wp-caption alignright\" style=\"width: 226px\"><a href=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3504\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-216x300.png\" alt=\"dr-jonathan-parr\" width=\"216\" height=\"300\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-216x300.png 216w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr-301x419.png 301w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/dr-jonathan-parr.png 350w\" sizes=\"auto, (max-width: 216px) 100vw, 216px\" \/><\/a><figcaption class=\"caption wp-caption-text\">Jonathan Parr, MD<\/figcaption><\/figure>\n<p><a href=\"https:\/\/www.med.unc.edu\/medicine\/infdis\/ideel\/directory\/jonathan-parr\/\">Jonathan Parr<\/a>, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in <em><a href=\"https:\/\/www.the-scientist.com\/news-opinion\/researchers-create-completely-self-contained-covid-test-with-3d-printed-parts-69080\">The Scientist<\/a><\/em> about the\u00a0development of CRISPR diagnostics.<\/p>\n<p>Since the start of the COVID-19 pandemic, researchers have been <a href=\"https:\/\/www.the-scientist.com\/news-opinion\/toward-covid-19-testing-any-time-anywhere-67906\" target=\"_blank\" rel=\"noopener noreferrer\">striving<\/a> to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers based at Harvard University\u2019s Wyss Institute and MIT have unveiled a quick and inexpensive testing platform capable of distinguishing between major SARS-CoV-2 variants, according to a paper published in <a href=\"https:\/\/advances.sciencemag.org\/lookup\/doi\/10.1126\/sciadv.abh2944\" target=\"_blank\" rel=\"noopener noreferrer\"><em>Science Advances<\/em><\/a>.<\/p>\n<p>Parr said one major limitation of the current study is that the platform miSHERLOCK was only tested on 27 clinical samples in an email to <em>The Scientist<\/em>. \u00a0Parr develops CRISPR-based diagnostics for malaria but was not involved with the current study. The sample donors were all COVID-19 patients from the Dominican Republic and none were infected with variants of concern, he adds. While the authors acknowledge the paucity of clinical samples in their paper, Parr says \u201cit raises concerns about the \u2018real world\u2019 performance of their assay nonetheless.\u201d<\/p>\n<p><a href=\"https:\/\/www.the-scientist.com\/news-opinion\/researchers-create-completely-self-contained-covid-test-with-3d-printed-parts-69080\">Read the article.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jonathan Parr, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in The Scientist about the\u00a0development of CRISPR diagnostics. Since the start of the COVID-19 pandemic, researchers have been striving to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers based &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\" aria-label=\"Read more about Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics\">Read more<\/a><\/p>\n","protected":false},"author":69419,"featured_media":4334,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[640,100,2],"tags":[630],"class_list":["post-54913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fellowship","category-infectious-diseases","category-news","tag-630","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Jonathan Parr, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in The Scientist about the\u00a0development of CRISPR diagnostics. Since the start of the COVID-19 pandemic, researchers have been striving to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers based &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-31T00:16:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:14:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"410\" \/>\n\t<meta property=\"og:image:height\" content=\"574\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics\",\"datePublished\":\"2021-08-31T00:16:28+00:00\",\"dateModified\":\"2023-06-06T22:14:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\"},\"wordCount\":198,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png\",\"keywords\":[\"2021\"],\"articleSection\":[\"Fellowship\",\"Infectious Diseases\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\",\"name\":\"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png\",\"datePublished\":\"2021-08-31T00:16:28+00:00\",\"dateModified\":\"2023-06-06T22:14:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png\",\"width\":410,\"height\":574,\"caption\":\"About five percent of people living in the Democratic Republic of the Congo have hepatitis B virus says Jonathan Parr, MD, MPH.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/","og_locale":"en_US","og_type":"article","og_title":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine","og_description":"Jonathan Parr, MD, MPH, assistant professor in the division of infectious diseases, was interviewed for an article in The Scientist about the\u00a0development of CRISPR diagnostics. Since the start of the COVID-19 pandemic, researchers have been striving to develop low-cost tests to detect the presence of SARS-CoV-2 in patient samples. Now, a team of researchers based &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2021-08-31T00:16:28+00:00","article_modified_time":"2023-06-06T22:14:14+00:00","og_image":[{"width":410,"height":574,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","type":"image\/png"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics","datePublished":"2021-08-31T00:16:28+00:00","dateModified":"2023-06-06T22:14:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/"},"wordCount":198,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","keywords":["2021"],"articleSection":["Fellowship","Infectious Diseases","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/","name":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","datePublished":"2021-08-31T00:16:28+00:00","dateModified":"2023-06-06T22:14:14+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","width":410,"height":574,"caption":"About five percent of people living in the Democratic Republic of the Congo have hepatitis B virus says Jonathan Parr, MD, MPH."},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/parr-interviewed-by-the-scientist-about-the-development-of-crispr-diagnostics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Parr Interviewed By The Scientist About the Development of CRISPR Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2-214x300.png","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2.png","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2018\/12\/a-gillings-innovation-lab-award-funds-hepatitis-prevention-in-africa-1-image2-150x150.png","featured_image_alt":"About five percent of people living in the Democratic Republic of the Congo have hepatitis B virus says Jonathan Parr, MD, MPH.","category_details":[{"name":"Fellowship","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/fellowship\/"},{"name":"Infectious Diseases","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/infectious-diseases\/"},{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"}],"tag_details":[{"name":"2021","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2021\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/54913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=54913"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/54913\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/4334"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=54913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=54913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=54913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}